Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial

被引:0
|
作者
Jingjing Wu
Lingling Duan
Lei Zhang
Zhenchang Sun
Xiaorui Fu
Xin Li
Ling Li
Xinhua Wang
Xudong Zhang
Zhaoming Li
Hui Yu
Yu Chang
Feifei Nan
Jiaqin Yan
Li Tian
Xiaoli Wang
Mingzhi Zhang
机构
[1] The First Affiliated Hospital of Zhengzhou University,Department of Oncology, Lymphoma Diagnosis and Treatment Centre of Henan Province
来源
Journal of Neuro-Oncology | 2018年 / 140卷
关键词
Teniposide; Methotrexate; Primary CNS lymphoma; Chemotherapy; Whole-brain radiotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:427 / 434
页数:7
相关论文
共 50 条
  • [21] High-dose methotrexate, high-dose cytarabine and temozolomide for the treatment of primary central nervous system lymphoma (PCNSL)
    Salamoon, Maher
    Hussein, Taisir
    Kenj, Mazen
    Bachour, Marrouan
    MEDICAL ONCOLOGY, 2013, 30 (04)
  • [22] High-dose methotrexate-based chemotherapy for induction remission of newly diagnosed primary CNS lymphoma: A systematic review and meta-analysis
    Shi, Han
    Sun, Xuefei
    Wu, Yuchen
    Cui, Qu
    Sun, Shengjun
    Ji, Nan
    Liu, Yuanbo
    MEDICINE, 2025, 104 (05) : e41363
  • [23] SFOPOS94:: A randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients
    Le Deley, Marie-Cecile
    Guinebretiere, Jean-Marc
    Gentet, Jean-Claude
    Pacquement, Helene
    Pichon, Fabienne
    Marec-Berard, Perrine
    Entz-Werle, Natacha
    Schmitt, Claudine
    Brugieres, Laurence
    Vanel, Daniel
    Dupouy, Noelle
    Tabone, Marie-Dominique
    Kalifa, Chantal
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (04) : 752 - 761
  • [24] Clinical utility and pharmacology of high-dose methotrexate in the treatment of primary CNS lymphoma
    Green, Myke R.
    Chowdhary, Sajeel
    Lombardi, Kristina M.
    Chalmers, Lisa M.
    Chamberlain, Marc
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2006, 6 (05) : 635 - 652
  • [25] Treatment of Primary CNS Lymphoma With High-Dose Methotrexate in Immunocompetent Pediatric Patients
    Shah, Amish C.
    Kelly, David R.
    Nabors, L. Burt
    Oakes, W. Jerry
    Hilliard, Lee M.
    Reddy, Alyssa T.
    PEDIATRIC BLOOD & CANCER, 2010, 55 (06) : 1227 - 1230
  • [26] High-dose methotrexate-based regimens and post-remission consolidation for treatment of newly diagnosed primary CNS lymphoma: meta-analysis of clinical trials
    Yu, Junyao
    Du, Huaping
    Ye, Xueshi
    Zhang, Lifei
    Xiao, Haowen
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [27] Prognostic value of immunohistochemical profile and response to high-dose methotrexate therapy in primary CNS lymphoma
    Momota, Hiroyuki
    Narita, Yoshitaka
    Maeshima, Akiko M.
    Miyakita, Yasuji
    Shinomiya, Aya
    Maruyama, Takashi
    Muragaki, Yoshihiro
    Shibui, Soichiro
    JOURNAL OF NEURO-ONCOLOGY, 2010, 98 (03) : 341 - 348
  • [28] Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C
    Mishima, Kazuhiko
    Nishikawa, Ryo
    Narita, Yoshitaka
    Mizusawa, Junki
    Sumi, Minako
    Koga, Tomoyuki
    Sasaki, Nobuyoshi
    Kinoshita, Manabu
    Nagane, Motoo
    Arakawa, Yoshiki
    Yoshimoto, Koji
    Shibahara, Ichiyo
    Shinojima, Naoki
    Asano, Kenichiro
    Tsurubuchi, Takao
    Sasaki, Hikaru
    Asai, Akio
    Sasayama, Takashi
    Momii, Yasutomo
    Sasaki, Atsushi
    Nakamura, Shigeo
    Kojima, Masaru
    Tamaru, Junichi
    Tsuchiya, Kazuhiro
    Gomyo, Miho
    Abe, Kayoko
    Natsumeda, Manabu
    Yamasaki, Fumiyuki
    Katayama, Hiroshi
    Fukuda, Haruhiko
    NEURO-ONCOLOGY, 2023, 25 (04) : 687 - 698
  • [29] Crystalline Nephropathy With High-Dose Methotrexate in a Patient With Primary CNS Lymphoma: A Case Report
    Sami, Faria Latif
    Hammo, Hasan
    Athavale, Ambarish
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [30] Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma
    Yuan, Xianggui
    Yu, Teng
    Huang, Yurong
    Jiang, Huawei
    Xu, Xiaohua
    Liang, Yun
    Qian, Wenbin
    SCIENTIFIC REPORTS, 2022, 12 (01):